Dr. Elliot Goldstein and Shanti Skiffington discuss the future of medicine for Alzheimer’s and Parkinson’s diseases with the world's leading researchers.
Episode 31 – Audio white paper: Perspective on Aducanumab’s Nov. 6 Advisory Committee
This episode is a recording of the White Paper: Perspective on Aducanumab’s Nov. 6 Advisory Committee, read by Shanti Skiffington.
Episode 30 – Dr. Scott Napper on an Alzheimer’s Vaccine
This week Shanti and Eliot talk to Dr. Scott Napper, Professor of Biochemistry, Microbiology & Immunology at the University of Saskatchewan, about the future of an Alzheimer’s Vaccine.
Episode 29 – Detecting, treating, and preventing Alzheimer’s disease: Dr. Neil Cashman explains
On today's episode, Shanti and Eliot talk to Dr. Neil Cashman about a vaccine for Alzheimer’s disease and how that fits into the detection, treatment, and prevention of the disease.
Episode 28 – Dr. Josè Luis Molinuevo of the BarcelonaBeta Brain Research Center on his biomarker presentation at AAIC
Shanti and Eliot talk to Dr. Josè Luis Molinuevo of the BarcelonaBeta Brain Research Center about his experience at AAIC, and the presentation he gave on biomarkers.
Episode 27 – Using Artificial Intelligence to speed Alzheimer’s studies
This week, Shanti and Eliot talk to founder and CEO of Unlearn, Charles Fisher. They discuss how artificial intelligence can effect Alzheimer's drug research.
Episode 26 – A diagnostic test for Alzheimer’s disease
Shanti and Elliot talk to Dr. James Kupiec about a diagnostics test for Alzheimer's disease.